Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

Insel Gruppe AG, University Hospital Bern: Clinical Trials & FDA Approval Profile

Insel Gruppe AG, University Hospital Bern (Global / Institutional) sponsors 29 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 9 active protocols (8 recruiting now), 13 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)24.1%
Median Closed Enrollment vs National (145 pts)45 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Insel Gruppe AG, University Hospital Bern
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)29
Active Pipeline (Recruiting Now)9 (8)
Completed vs Stopped Early13 / 7 (24.1%)
Median Closed Actual Enrollment45 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Insel Gruppe AG, University Hospital Bern
Hospital Research SiteLocationShared Protocols
Kantonsspital St. GallenSankt Gallen4
Universitätsspital ZürichZurich3
Inselspital BernBern2

Explore interactive annual charts and M&A subsidiary rollups in the Insel Gruppe AG, University Hospital Bern Interactive Dossier, benchmark peers in Rare Genetic, Women's Health, and Other, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI